- 5 civilians dead, 5 officers wounded in Illinois shooting
- Community learns sign language to engage with 2-year-old girl
- Wall Street Week Ahead: Profit estimates may be adding in too much cost risk
- Anonymous donor helps Gold Star family
- Legal challenges to Trump emergency declaration face uphill battle
FILE PHOTO – Shoppers walk outside a CVS store and pharmacy in Medford, Massachusetts, U.S. December 4, 2017. REUTERS/Brian Snyder
October 10, 2018
WASHINGTON (Reuters) – Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination the companies say can help cut soaring U.S. healthcare costs.
It is the second large recent healthcare deal to win antitrust approval from the U.S. Justice Department. The agency gave the green light to health insurer Cigna Corp’s $52 billion acquisition of the nation’s largest pharmacy benefit manager, Express Scripts Holding Co, on Sept. 17.
(Reporting by Diane Bartz; Editing by Bill Berkrot)